Copyright
        ©The Author(s) 2004.
    
    
        World J Gastroenterol. Jun 15, 2004; 10(12): 1740-1745
Published online Jun 15, 2004. doi: 10.3748/wjg.v10.i12.1740
Published online Jun 15, 2004. doi: 10.3748/wjg.v10.i12.1740
            Table 1 Comparison of microarray and RNA slot analyses on 4 selected genes
        
    | Accession | X67325 | AB023136 | AA622328 | NM_018300 | ||||
| ID | Ratio of arrays | Ratio of slot | Ratio of arrays | Ratio of slot | Ratio of arrays | Ratio of slot | Ratio of arrays | Ratio of slot | 
| 6 h/0 h | 3.6 | Undetectable | 3.4 | 1.3 | 2.0 | 0.5 | 1.1 | 2.9 | 
| 24 h/0 h | 5.9 | > 31 | 7.2 | 3.5 | 3.9 | 1.6 | 4.9 | 3.4 | 
| 48 h/0 h | 6.1 | > 33 | 8.4 | 6.2 | 3.8 | 5.7 | 1.0 | 1.3 | 
| Description | IFN-inducible P27 | Sec15B(vesicle traffic protein) | beta3gal-T5 gene | cDNA FLJ12673 | ||||
            Table 2 Gene expression profiling in the microarray analysis
        
    | Ratio | Gene differences in HepG22.2.15 | Gene differences in HepG2 | Gene differences in HepG22.2.15/HepG2 | |||||||
| 6 h/0 h | 24 h/0 h | 48 h/0 h | 6 h/0 h | 24 h/0 h | 48 h/0 h | 0 h | 6 h | 24 h | 48 h | |
| 3 | 34 | 48 | 45 | 83 | 103 | 48 | 89 | 40 | 33 | 36 | 
| 5 | 10 | 18 | 12 | 37 | 37 | 23 | 27 | 12 | 8 | 11 | 
            Table 3 Differently expressed known genes in HepG2 2.2.15 and HepG2 cell lines before IFN-α treatment
        
    | Accession ID | HepG2 | HepG22.2.15 | Ratio | Description | Unigene | 
| Cell cycle | |||||
| Y13467 | 101.95 | 29.54 | -3.45 | RB18A | Hs.15589 | 
| Ligands and receptors | |||||
| AF022375 | 16.17 | 5.19 | -3.12 | vascular endothelial growth factor | Hs.73793 | 
| Phosphatase | |||||
| U12128 | 152.03 | 27.26 | -5.58 | tyrosine phosphatase 1E (PTP1E) | Hs.211595 | 
| Transcription factors | |||||
| D87258 | 156.76 | 37.78 | -4.15 | serin protease with IGF-binding motif | Hs.75111 | 
| Miscellaneous | |||||
| X69962 | 242.93 | 73.77 | -3.29 | FMR-1 | Hs.89764 | 
| X56597 | 1.64 | 21.98 | 13.40 | humFib mRNA for fibrillarin | Hs.99853 | 
| U76713 | 403.90 | 123.59 | -3.27 | apobec-1 binding protein 1 | Hs.81361 | 
| U50410 | 189.94 | 27.03 | -7.03 | heparan sulphate proteoglycan (OCI5) | Hs.119651 | 
| U23070 | 5.35 | 16.82 | 3.14 | putative transmembrane protein (nma) | Hs.78776 | 
| S68805 | 4.12 | 12.74 | 3.09 | L-arginine:glycine amidinotransferase | Hs.75335 | 
| M22430 | 13.63 | 50.17 | 3.68 | RASF-A PLA2 | Hs.76422 | 
| M16961 | 221.65 | 61.50 | -3.60 | alpha-2-HS-glycoprotein alpha and beta chain | Hs.75430 | 
| M13928 | 21.15 | 163.32 | 7.72 | delta-aminolevulinate dehydratase | Hs.1227 | 
| L40157 | 14.58 | 92.98 | 6.38 | endosome-associated protein (EEA1) | Hs.2864 | 
| L24123 | 1 309.05 | 430.92 | -3.04 | NRF1 protein (NRF1) | Hs.83469 | 
| D00096 | 7.61 | 31.28 | 4.11 | Prealbumin | Hs.194366 | 
| AJ006835 | 150.29 | 49.21 | -3.05 | U17 small nucleolar RNA host gene | Hs.196769 | 
| AF073308 | 237.11 | 78.45 | -3.02 | nonsyndromic hearing impairment protein (DFNA5) | Hs.13530 | 
| AF050127 | 823.97 | 71.21 | -11.57 | hypoxia inducible factor (aHIF) | Hs.197540 | 
| AC002045 | 237.87 | 67.71 | -3.51 | Chromosome 16 BAC clone CIT987SK-A-589H1 | Hs.253182 | 
| AB027013 | 15.62 | 2.31 | -6.76 | Nucleosome Assembly Protein 1-like 2 | Hs.66180 | 
| AB023136 | 544.25 | 44.18 | -12.32 | KIAA0919 | Hs.44175 | 
            Table 4 Functional catalogues of 3 fold regulated genes in HepG2 and HepG2 2.2.15 cell lines post IFN-α treatment
        
    | Catalogue | 3-fold regulated gene number in HepG22.2.15 | 3-fold regulated gene number in HepG2 | ||||
| 6 h/0 h | 24 h/0 h | 48 h/0 h | 6 h/0 h | 24 h/0 h | 48 h/0 h | |
| Cell cycle | - | 1 | 1 | - | - | - | 
| Coagulation | - | 1 | 1 | - | 1 | - | 
| Cytokine/receptors | 1 | 2 | 2 | 1 | 1 | - | 
| Extracellular matrix and cell adhesion | - | - | 1 | - | 1 | - | 
| GTP binding proteins and signal transduction | 2 | - | 1 | - | 1 | 1 | 
| Interferon | 8 | 6 | 3 | 6 | 5 | 5 | 
| Kinase and phosphatase | - | - | 1 | - | 2 | - | 
| Ligands and receptors | - | 1 | 2 | - | - | - | 
| Mitochondrial | - | 1 | 1 | - | 2 | - | 
| Phosphatase and phosphodiesterase | 2 | 2 | 2 | 1 | 2 | 1 | 
| Protooncogenes | - | 1 | - | 1 | - | - | 
| Transcription factors | - | - | - | 1 | 1 | 1 | 
| Viral and clathrin receptors | - | 1 | 1 | - | 1 | - | 
| Miscellaneous | 7 | 8 | 8 | 14 | 18 | 13 | 
| New ESTs | 14 | 24 | 21 | 59 | 68 | 27 | 
| Total | 34 | 48 | 45 | 83 | 103 | 48 | 
            Table 5 Kinetics of IFN-treated gene expression profiles in 23 selected genes from HepG2 and HepG22.2.15 cells
        
    | Accession ID | HepG22.2.15 cell lines | HepG2 cell lines | Description | ||||
| 6 h/0 h | 24 h/0 h | 48 h/0 h | 6 h/0 h | 24 h/0 h | 48 h/0 h | ||
| Interferon | |||||||
| X57352 | 3.8 | 3.1 | 2.5 | 6.5 | 8.1 | 6.4 | 1-8U gene from interferon-inducible gene family | 
| X57351 | 3.4 | 2.2 | 2.2 | 4.3 | 4.4 | 4.4 | 1-8U gene from interferon-inducible gene family | 
| M87503 | 2.3 | 1.7 | 1.7 | 3.2 | 2.4 | 2.6 | IFN-responsive transcription factor subunit | 
| M33882 | 2.4 | 1.6 | 1.5 | 2.5 | 2.1 | 1.6 | p78 protein | 
| M11810 | 9.1 | 5.7 | 4.4 | 8.4 | 7.7 | 3.9 | (2’-5’) oligo A synthetase E gene | 
| L07633 | 2.0 | 1.3 | 1.5 | 2.0 | 2.7 | 1.3 | (clone 1950.2) interferon-gamma IEF SSP 5111 | 
| J04164 | 6.7 | 5.0 | 2.9 | 6.4 | 7.0 | 6.5 | Interferon-inducible protein 9-27 | 
| D28137 | 3.0 | 3.3 | 2.8 | 2.7 | 2.6 | 1.8 | BST-2 | 
| AJ225089 | 3.9 | 1.3 | 1.1 | 1.9 | 2.1 | 1.2 | 2’-5’ oligoadenylate synthetase 59 kDa isoform | 
| Kinase/Phosphate | |||||||
| U07358 | -1.3 | -1.3 | -2.5 | 1.1 | 2.4 | 1.4 | Protein kinase (zpk) | 
| U02680 | -1.1 | 1.4 | -2.5 | 1.5 | 7.1 | 1.6 | Protein tyrosine kinase | 
| AF032437 | -1.1 | -2.5 | -1.7 | -1.3 | -3.3 | -2.0 | Mitogen activated protein kinase activated protein kinase | 
| Ligands and receptors | |||||||
| D86096 | 2.3 | 4.6 | 3.5 | 1.9 | 1.8 | 2.3 | Prostaglandin E receptor EP3 subtype | 
| AF022375 | 1.8 | 1.8 | 3.2 | -1.2 | -1.1 | 1.1 | Vascular endothelial growth factor | 
| Phosphatase | |||||||
| U12128 | 3.0 | 4.8 | 4.7 | -1.2 | -1.1 | -1.2 | Protein tyrosine phosphatase 1E (PTP1E) | 
| Protein degradation | |||||||
| Z14977 | 2.2 | 1.2 | 1.4 | 2.7 | 1.3 | 1.6 | Major histocompatibility complex encoded | 
| proteasome subunit LMP2 | |||||||
| AF061736 | 2.6 | 1.5 | 1.4 | 2.3 | 2.3 | 2.0 | Ubiquitin-conjugating enzyme RIG-B | 
| Protooncogenes | |||||||
| U52969 | 1.1 | -2.0 | -1.3 | 2.2 | 1.6 | 2.1 | PEP19 (PCP4) | 
| U50529 | -2.5 | -5.0 | -2.5 | 1.7 | 1.5 | 2.2 | BRCA2 region, mRNA sequence CG016 | 
| Transcription factors | |||||||
| D87258 | 1.6 | 2.3 | 2.5 | 1.0 | -1.1 | -1.5 | Serin protease with IGF-binding motif | 
| Viral and clathrin receptors | |||||||
| X81636 | 1.1 | 5.5 | 5.2 | -1.1 | 6.4 | -1.7 | Clathrin light chain a | 
| U70321 | -1.3 | -2.0 | 1.1 | 2.0 | 1.2 | 1.6 | Herpesvirus entry mediator | 
| AF079221 | 1.0 | 1.2 | 2.9 | 1.7 | 2.2 | 1.9 | BCL2/adenovirus E1B 19kDa-interacting protein 3 a | 
- Citation: Wang X, Yuan ZH, Zheng LJ, Yu F, Xiong W, Liu JX, Hu GX, Li Y. Gene expression profiles in an hepatitis B virus transfected hepatoblastoma cell line and differentially regulated gene expression by interferon-α. World J Gastroenterol 2004; 10(12): 1740-1745
- URL: https://www.wjgnet.com/1007-9327/full/v10/i12/1740.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i12.1740

 
         
                         
                 
                 
                 
                 
         
                         
                         
                        